PAPER
SEARCH RESULTS
330026 RESULTS
PAPER Morgan JC Jr, Currie LJ, Harrison MB, Bennett JP, Trugman JM, Wooten GF
Mortality in levodopa-treated Parkinson's disease.
Parkinsons Dis. 2014;2014:426976. Epub 2014 Jan 28 PubMed: 24616821PAPER Litvan I, Kong M
Rate of decline in progressive supranuclear palsy.
Mov Disord. 2014 Apr;29(4):463-8. Epub 2014 Feb 24 PubMed: 24615741PAPER Levin J, Schmidt F, Boehm C, Prix C, Bötzel K, Ryazanov S, Leonov A, Griesinger C, Giese A
The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset.
Acta Neuropathol. 2014 Mar 11; PubMed: 24615514PAPER Lotan I, Treves TA, Roditi Y, Djaldetti R
Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study.
Clin Neuropharmacol. 2014 Mar-Apr;37(2):41-4. PubMed: 24614667PAPER Sahin G, Thompson LH, Lavisse S, Ozgur M, Rbah-Vidal L, Dollé F, Hantraye P, Kirik D
Differential dopamine receptor occupancy underlies L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
PLoS One. 2014;9(3):e90759. Epub 2014 Mar 10 PubMed: 24614598PAPER Kim YE, Jeon BS
Genetic susceptibility of impulse control and related behavior in Parkinson's disease.
J Parkinsons Dis. 2014;4(2):261-72. PubMed: 24613866PAPER Klingelhoefer L, Samuel M, Chaudhuri KR, Ashkan K
An update of the impact of deep brain stimulation on non motor symptoms in Parkinson's disease.
J Parkinsons Dis. 2014;4(2):289-300. PubMed: 24613865PAPER Chen T, Li J, Chao D, Sandhu HK, Liao X, Zhao J, Wen G, Xia Y
δ-Opioid receptor activation reduces α-synuclein overexpression and oligomer formation induced by MPP(+) and/or hypoxia.
Exp Neurol. 2014 May;255:127-36. Epub 2014 Mar 5 PubMed: 24613828PAPER Wang Q, Wei X, Gao H, Li J, Liao J, Liu X, Qin B, Yu Y, Deng C, Tang B, Huang XF
Simvastatin reverses the downregulation of M1/4 receptor binding in 6-hydroxydopamine-induced parkinsonian rats: the association with improvements in long-term memory.
Neuroscience. 2014 May 16;267:57-66. Epub 2014 Mar 5 PubMed: 24613723PAPER Carriere CH, Kang NH, Niles LP
Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
Neuroscience. 2014 May 16;267:114-21. Epub 2014 Mar 6 PubMed: 24613722PAPER Matías-Guiu JA, García-Ramos R, Cabrera-Martín MN, Moreno-Ramos T
Logopenic progressive aphasia associated to idiopathic Parkinson's disease.
Neurologia. 2014 Mar 6; PubMed: 24613045PAPER Lanni KE, Ross JM, Higginson CI, Dressler EM, Sigvardt KA, Zhang L, Malhado-Chang N, Disbrow EA
Perceived and performance-based executive dysfunction in Parkinson's disease.
J Clin Exp Neuropsychol. 2014 Mar 10; PubMed: 24611823PAPER Bloch J, Brunet JF, McEntire CR, Redmond DE
Primate adult brain cell autotransplantation produces behavioral and biological recovery in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian St. Kitts monkeys.
J Comp Neurol. 2014 Aug 15;522(12):2729-40. Epub 2014 Apr 4 PubMed: 24610674PAPER Buttery PC, Barker RA
Treating Parkinson's disease in the 21st century: Can stem cell transplantation compete?
J Comp Neurol. 2014 Aug 15;522(12):2802-16. Epub 2014 Apr 4 PubMed: 24610597Current Filters
No filters selected